Site Map

The field of RNA interference represents a potential revolution in medicine and a new approach to treating disease.  Aonys provides a highly protective environment for both native and modified oligonucleotides and allows buccal administration and absorption.

Diabetes mellitus is a chronic disease accounting for 90% of all diagnosed diabetes cases and is mainly characterised by elevated blood glucose levels resulting from defects in insulin secretion and insulin action.

Neurodegeneration refers to the progressive loss of neuron function leading to a variety of pathologies involving both motor function and dementia.

Aonys® provides a highly efficient delivery mechanism to both metal ions and other pharmacologically active molecules, increasing cellular bioavailability significantly allowing lower administered doses and thus reducing toxic effects due to accumulation.

A new pharmaceutical product based upon vanadium and Aonys, NP01 improves insulin sensitivity leading to insulin-sensitisation of peripheral tissues.

A new pharmaceutical product based upon lithium and Aonys, NP03 has been shown to have a neuroprotector role which could have uses in a number of neurodegerative diseases.

A new pharmaceutical product based upon lithium and Aonys, NP07 is a potent mood stabiliser for the treatment of bipolar disporder.  Current "gold standard" lithium treatment for bipolar disorder requires constant patient monitoring to achieve the balance between therapeutic and undesirable effects.  Due to difficulties in maintaining this balance, a significant number of patients are unable to maintain satisfactory mood stabilisation.

The field of RNA interference represents a potential revolution in medicine and a new approach to treating disease.

“A great investment opportunity occurs when a marvelous business encounters a one-time, but solvable problem. you just need to know the business to recognize this”. - Warren Buffet

Medesis Pharma is a privately owned clinical stage pharmaceutical company created to develop a wide range of therapeutic agents based upon propriety Aonys® drug delivery technology.

Good management is the art of making problems so interesting and their solutions so constructive that everyone wants to get to work and deal with them. - Paul Hawken

“All knowledge is connected to all other knowledge. The fun is in making the connections.” Arthur Aufderheide